A study of human leukocyte antigen G expression in hydatidiform moles

American Journal of Obstetrics and Gynecology

Volumn 185, Issue 2, 2001, Pages 476-480

  Goldman Wohl, Debra ^a   Ariel, Ilana ^a   Greenfield, Caryn ^a   Hochner Celnikier, Drorit ^a   Lavy, Yuval ^a   Yagel, Simcha ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Complete hydatidiform mole; Human leukocyte antigen G; Partial hydatidiform mole; Placenta

Indexed keywords

HLA ANTIGEN; LEUKOCYTE ANTIGEN G; RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; IN SITU HYBRIDIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PREGNANCY; PRIORITY JOURNAL; PROTECTION; TROPHOBLAST;

EID: 0034881891     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.115994     Document Type: Article

References (26)

1. The major histocompatibility complex: An important factor in every stage of pregnancy from preimplantation to birth? Part I
2. A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions
3. Placental HLA-G protein expression in vivo: Where and what for?
4. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells
5. The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
6. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with preeclampsia
7. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia
8. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-HLA-G-specific antibody "87G" and anti-cytokeratin antibody "CAM5.2."
9. Choriocarcinoma cell line resistance to NK lysis mainly involves an HLA-G-independent mechanism
10. Tumors of the uterine corpus and gestational trophoblastic disease
11. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 nonmolar hydropic abortions
12. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts
13. Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation
14. Chorionic tumors
15. Characterization and localization of HLA antigens on hydatidiform mole
16. Reaction patterns of monoclonal antibodies to HLA-G in human tissues and on cell lines: A comparative study
17. The relation between hydatid moles, relative ischemia of the gravid uterus and the placental origin of eclampsia
18. HLA-G polymorphisms: Ethnic differences and implications for potential molecule function
19. Imprinting
20. Epigenetic gene silencing in cancer
21. Completion of mouse embryogenesis requires both the maternal and paternal genomes
22. Biparental alleles of HLA-G are co-dominantly expressed in the placenta
23. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast
24. Molecular studies of trophoblast HLA-G: Polymorphism, isoforms, imprinting and expression in preimplantation embryo
25. Oppositely imprinted genes H19 and insulin-like growth factor 2 are co-expressed in human androgenetic trophoblast
26. Relaxation of imprinting in trophoblastic disease